Skip to content

A study to predict perinatal outcomes using biomarkers in amniotic fluid and neonatal urine

Comparative Evaluation of Amniotic Fluid and Neonatal Urinary NGAL and L-FABP for Predicting Perinatal Outcomes: A Prospective Observational Study - AFNU Biomarker Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1050260071
Enrollment
200
Registered
2026-06-09
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women

Interventions

None listed

Sponsors

katsura daisuke
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women aged 18 years or older at enrollment, at 22 weeks of gestation or later, who fully understand the study procedures and provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients will be excluded if the fetus has severe fetal anomalies, chromosomal abnormalities, or genetic abnormalities; if the attending physician judges participation in the study to be inappropriate; or if the mother or fetus requires emergency management, such as for umbilical cord prolapse, fetal-placental dysfunction, massive genital bleeding due to placenta previa, uterine rupture, or other urgent maternal or fetal conditions.

Design outcomes

Primary

MeasureTime frame
Predictive ability of NGAL and L-FABP levels in amniotic fluid at delivery and in neonatal urine after birth for neonatal death (death within 28 days after birth), infant death, and neurological sequelae at 2 years of age, including cerebral palsy and developmental delay (developmental quotient <85 on the Kyoto Scale of Psychological Development).

Secondary

MeasureTime frame
Correlation between NGAL and L-FABP levels in amniotic fluid at delivery and those in neonatal urine after birth. Correlation between NGAL and L-FABP levels in amniotic fluid at delivery and those in umbilical cord blood. Association of each biomarker with adverse perinatal outcomes, including NICU admission, respiratory distress syndrome, mechanical ventilation, neonatal sepsis, necrotizing enterocolitis, and intraventricular hemorrhage. Comparison of the predictive ability of amniotic fluid biomarkers and neonatal urinary biomarkers based on the area under the curve in ROC analysis. Correlations of beta2-microglobulin and cystatin C with NGAL and L-FABP, and their associations with adverse perinatal outcomes.

Contacts

Public ContactDaisuke katsura

Shiga University of Medical Science Hospital

hqgyne@belle.shiga-med.ac.jp+81-775482267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026